The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
http://novacyt.com/wp-content/uploads/2021/12/Ncyt-Omicron_2021-12-15-12-01-27.pdf
http://novacyt.com/wp-content/uploads/2021/12/Ncyt-Omicron_2021-12-15-12-01-27.pdfHave a gander
https://www.brighttalk.com/webcast/18699/482779?utm_campaign=channel-feed&utm_source=brighttalk-portal&utm_medium=web
Ncyt webinar this Friday.
And at my age any rise is a good one..... I’m happy with consistency over the next week or so..... 5% a day would show some real consolidation, and lessen the effect of increased trigger selling at certain price points.
22-Apr-21 15:46:02 6.50 291,649 Sell* 18.96k
This entry is incorrect. I know this because it’s mine. Was invested here for ages. Had a meltdown when Ncyt plummeted and sold all my holdings in a fit of wtf moment. Luckily still had profits so came back in today after seeing a steady and consistent rise over the past week. I anticipate a small drop back at some stage, especially if other buys are shown as sells! Still it should right itself in time and return on the upward trajectory.
Just pointing out the error for others to take into account.
Ok I’m now getting bored with the inevitable aim drift on no news. GM, you’re a cool dude, how about a cheeky update on the vast range of the tests you have bouncing around the world. Just something to keep me in the loop.
Thanks
Si
Testing won’t end after the vaccine. Everyone in the science world has been very clear on that. In fact testing is vital when you consider what it’s for....... other forms of testing compliments pcr not operate in competition.
Like others I’ve been here for ages and have gone through the same peaks and troughs, albeit at a lower price. What you must remember, whilst sitting on a paper loss, is Nothing has changed for the worse. In the background this company is moving forward. Even if we get little news regularly the rate and type of employment increase shows that there is a need for expansion.
I listened to the webinar today. It was about testing, for those that didn’t listen. What is very clear is all test types have their place, and should not be seen as competitors to each other, but complimentary. And testing is the backbone to managing pandemics. The vaccine has its place but, even after we have all even jabbed, testing will stay and even become a way of life for the next few years. And, I hate to say, for the next pandemic.
I have faith in the big cheese in charge. His strategy hasn’t let us down yet, and he is always seeking to be ahead of the curve, unlike some of my other interests who still haven’t got to market with their products.
So sit tight, accept that on aim with this share no news equals a drift to a lower price point, and wait. It’s worked for me three times, even though in hindsight I could have de risked by investment but didn’t. (My mistake).
I still think we shall see at least £12 a share in the coming months.
Good luck all.
Yes I’m still here..... watching And forced waiting!! Hopefully not for too much longer....... trouble has been a bit less than normal forthright rns. And the usual drift as a result. I afraid this will level out about this price until we get one thing solid on da cash front...... money talks on aim.....